[go: up one dir, main page]

WO2007038425A3 - Anti-viral compouinds - Google Patents

Anti-viral compouinds Download PDF

Info

Publication number
WO2007038425A3
WO2007038425A3 PCT/US2006/037241 US2006037241W WO2007038425A3 WO 2007038425 A3 WO2007038425 A3 WO 2007038425A3 US 2006037241 W US2006037241 W US 2006037241W WO 2007038425 A3 WO2007038425 A3 WO 2007038425A3
Authority
WO
WIPO (PCT)
Prior art keywords
viral
compouinds
compounds
administering
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/037241
Other languages
French (fr)
Other versions
WO2007038425A2 (en
Inventor
David M Ferguson
John Goodell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Minnesota Twin Cities
University of Minnesota System
Original Assignee
University of Minnesota Twin Cities
University of Minnesota System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Minnesota Twin Cities, University of Minnesota System filed Critical University of Minnesota Twin Cities
Publication of WO2007038425A2 publication Critical patent/WO2007038425A2/en
Publication of WO2007038425A3 publication Critical patent/WO2007038425A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides anti-viral compounds of formula (I) wherein R1-R3 and A have any of the values defined herein. The invention also provides pharmaceutical compositions comprising such compounds as well as methods for treating viral infections by administering such compounds to an animal.
PCT/US2006/037241 2005-09-27 2006-09-26 Anti-viral compouinds Ceased WO2007038425A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72100205P 2005-09-27 2005-09-27
US60/721,002 2005-09-27

Publications (2)

Publication Number Publication Date
WO2007038425A2 WO2007038425A2 (en) 2007-04-05
WO2007038425A3 true WO2007038425A3 (en) 2007-10-25

Family

ID=37900358

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/037241 Ceased WO2007038425A2 (en) 2005-09-27 2006-09-26 Anti-viral compouinds

Country Status (1)

Country Link
WO (1) WO2007038425A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9242960B2 (en) 2009-04-03 2016-01-26 Respivert, Ltd. P38MAP kinase inhibitors

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008137408A1 (en) 2007-04-30 2008-11-13 Genentech, Inc. Pyrazole inhibitors of wnt signaling
GB0818033D0 (en) 2008-10-02 2008-11-05 Respivert Ltd Novel compound
EP2350049B1 (en) 2008-10-02 2014-02-26 Respivert Limited P38 map kinase inhibitors
NZ593104A (en) 2008-12-11 2012-11-30 Respivert Ltd P38 map kinase inhibitors
CA2658259A1 (en) * 2009-03-12 2010-09-12 Institut Pasteur Dengue virus-like particle and uses thereof
JP6170043B2 (en) 2011-07-01 2017-07-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Dihydropyrazole
US9199975B2 (en) 2011-09-30 2015-12-01 Asana Biosciences, Llc Biaryl imidazole derivatives for regulating CYP17
US8809372B2 (en) 2011-09-30 2014-08-19 Asana Biosciences, Llc Pyridine derivatives
CN106632278A (en) * 2016-12-16 2017-05-10 黄子为 Heterocyclic nitrogen compound and application thereof
AU2019445303B2 (en) 2019-04-12 2025-10-02 Stryker Corporation Manifold for a medical waste collection system
WO2023081312A1 (en) * 2021-11-04 2023-05-11 Vir Biotechnology, Inc. Small molecule inducers of autophagy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837851A (en) * 1973-01-15 1974-09-24 Ibm Photoconductor overcoated with triarylpyrazoline charge transport layer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837851A (en) * 1973-01-15 1974-09-24 Ibm Photoconductor overcoated with triarylpyrazoline charge transport layer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9242960B2 (en) 2009-04-03 2016-01-26 Respivert, Ltd. P38MAP kinase inhibitors

Also Published As

Publication number Publication date
WO2007038425A2 (en) 2007-04-05

Similar Documents

Publication Publication Date Title
WO2008005565A3 (en) Antiviral phosphinate compounds
WO2009111653A3 (en) Antiviral therapeutic agents
WO2009026179A3 (en) Antiinfective proanthocyanidin compounds and methods of use thereof
EA021522B9 (en) Anti parasitic dihydroazole compounds and compositions comprising same
WO2009005677A3 (en) Antiviral compounds
WO2009005676A3 (en) Antiviral compounds
WO2009152356A3 (en) Compounds and compositions useful for the treatment of malaria
WO2009046314A3 (en) Moenomycin analogs, methods of synthesis, and uses thereof
TW200639169A (en) Bicyclic heteroaryl derivatives for treating viruses
WO2008013838A3 (en) Pyridizinone derivatives
WO2007112028A3 (en) 2'-fluoronucleoside phosphonates as antiviral agents
WO2010029302A3 (en) Compounds for treating viral infections
WO2008057208A3 (en) Hcv ns3 protease inhibitors
WO2008051514A3 (en) Hcv ns3 protease inhibitors
WO2008051475A3 (en) Hcv ns3 protease inhibitors
WO2007090623A3 (en) Fungicidal compositions
GEP20156263B (en) Substituted azoles, anti-viral active ingredient, pharmaceutical composition, method for production and usage thereof
WO2010057101A3 (en) Compounds useful as hiv blockers
EA200802058A1 (en) DERIVATIVES OF CYCLO-ALKYLAMINO ACIDS AND THEIR PHARMACEUTICAL COMPOSITIONS
WO2008115281A3 (en) Compounds for treating viral infections
WO2008021927A3 (en) Hepatitis c virus inhibitors
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
WO2008051477A3 (en) Hcv ns3 protease inhibitors
WO2008070129A3 (en) Compositions and methods for the treatment of inflammatory disease
WO2008048589A3 (en) Compounds and methods for treatment of hcv

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06815326

Country of ref document: EP

Kind code of ref document: A2